Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use... read more Featured Products: More products

Download Mobile App





2021 AACC Annual Scientific Meeting & Clinical Lab Expo to Offer Free Onsite COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Sep 2021
In its ongoing efforts to make the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo safe and healthy, the American Association for Clinical Chemistry (AACC; Washington, DC, USA), in association with LumiraDx (London, UK), will offer free onsite COVID-19 testing to all in-person attendees.

This year's AACC Annual Scientific Meeting, held in partnership with the Canadian Society of Clinical Chemists, will be a live event and has moved from Anaheim to Atlanta due to stringent COVID-19 lockdown requirements in California, with the meeting dates also being moved by one week to September 26-30. The latest move to offer onsite COVID-19 testing at the in-person meeting comes on top of the event’s already robust safety protocols that require all meeting participants to be vaccinated, and all meeting participants to have received a negative PCR or antigen COVID-19 test within 72 hours of arriving at the convention center.

To make the testing requirement as convenient as possible, AACC in association with LumiraDX will provide an onsite mobile testing unit outside the convention centre main doors where all in-person attendees can obtain a free COVID-19 test on a first come, first served basis. The results will take 30 minutes from sample collection. Attendees can avoid the necessity of fitting testing into their conference schedule by securing a test before leaving for Atlanta, as long as it falls within the three-day window. Additionally, the AACC will provide the attendees with COVID-19 self-test packets while they are at the conference and also as they prepare to return home, although supplies will be limited to the first 3,000 requests.

Related Links:
American Association for Clinical Chemistry
LumiraDx



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
High Performance Centrifuge
CO336/336R
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.